Georgia's Online Cancer Information Center

Find A Clinical Trial

A Phase 1 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors

Status
Active
Cancer Type
Unknown Primary
Trial Phase
Phase I
Eligibility
18 and over, Male and Female
Study Type
Biomarker/Laboratory analysis
Treatment
NCD ID
NCT02503774
Protocol IDs
D6070C00001 (primary)
NCI-2015-01857
Study Sponsor
MedImmune Inc

Summary

The purpose of this study is to Evaluate the Safety, Tolerability, Pharmacokinetics,

Immunogenicity, and Antitumor Activity of MEDI9447 Alone and in Combination with MEDI4736 in

Adult Subjects with Select Advanced Solid Tumors

Treatment Sites in Georgia

Piedmont Cancer Institute - Fayetteville


1267 Highway 54 West
Suite 4200
Fayetteville, GA 30214
www.piedmontcancerinstitute.com

Study Coordinator:
Ann Johnston
678-298-3235

Doctors:

Jonathan C. Bender MD
Trevor M. Feinstein MD
Rajni Sinha MD

Piedmont Cancer Institute - Newnan


775 Poplar Road
Suite 310
Newnan, GA 30265
www.piedmontcancerinstitute.com

Study Coordinator:
Ann Johnston
678-298-3235

Doctors:

Vasily J. Assikis MD
Minesh D. Patel MD

Piedmont Cancer Institute - Stockbridge


1240 Eagles Landing Parkway
Suite 260
Stockbridge, GA 30281
www.piedmontcancerinstitute.com

Study Coordinator:
Ann Johnston
678-298-3235

Doctors:

Eric D. Mininberg MD
Ha N. Tran MD
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.